NO-loaded Zn2+-exchanged zeolite materials: A potential bifunctional anti-bacterial strategy
Source abstract
Abstract
Nitric oxide (NO) is important for the regulation of a number of diverse biological processes, including vascular tone, neurotransmission, inflammatory cell responsiveness, defence against invading pathogens and wound healing. Transition metal exchanged zeolites are nanoporous materials with high-capacity storage properties for gases such as NO. The NO stores are liberated upon contact with aqueous environments, thereby making them ideal candidates for use in biological and clinical settings. Here, we demonstrate the NO release capacity and powerful bactericidal properties of a novel NO-storing Zn(2+)-exchanged zeolite material at a 50 wt.% composition in a polytetrafluoroethylene polymer. Further to our published data showing the anti-thrombotic effects of a similar NO-loaded zeolite, this study demonstrates the anti-bacterial properties of NO-releasing zeolites against clinically relevant strains of bacteria, namely Gram-negative Pseudomonas aeruginosa and Gram-positive methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Clostridium difficile. Thus our study highlights the potential of NO-loaded zeolites as biocompatible medical device coatings with anti-infective properties.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium Oxide Properties and Applications · Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. A randomized crossover study of silver-coated urinary catheters in hospitalized patients10.1001/archinte.160.21.3294 ↗
2. Catheter-associated urinary tract infections10.1016/S0924-8579(00)00359-9 ↗
3. Engineering out the risk for infection with urinary catheters10.3201/eid0702.010240 ↗
4. Treatment of urinary tract infection. Clinical and economic considerations10.2165/00019053-199609040-00003 ↗
5. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance10.1016/j.ajic.2004.05.002 ↗
6. Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters10.1016/S0140-6736(86)92629-2 ↗
7. Silver alloy coated catheters reduce catheter-associated bacteriuria10.1111/j.1464-410X.1990.tb14760.x ↗
8. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis10.1023/A:1005904704618 ↗
9. Nitric oxide and its role in apoptosis10.1016/S0014-2999(98)00274-X ↗
10. Nitric oxide and macrophage function10.1146/annurev.immunol.15.1.323 ↗
11. Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism10.1016/S0006-2952(99)00329-9 ↗
12. Biosynthesis and actions of nitric oxide
13. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins
14. Nitric oxide-dependent killing of Candida albicans by murine peritoneal cells during an experimental infection10.1111/j.1574-695X.1995.tb00112.x ↗
15. Antibacterial effect of nitric oxide
16. The anti-parasitic effects of nitric oxide10.1080/15216540310001639265 ↗
17. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites10.1084/jem.181.6.2171 ↗
18. Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters10.1021/ac991370c ↗
19. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release10.1016/S0142-9612(99)00127-1 ↗
20. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts10.1016/j.jvs.2004.07.007 ↗
21. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model
22. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB10.1016/S0735-1097(99)00543-4 ↗
23. Antibacterial nitric oxide-releasing xerogels: cell viability and parallel plate flow cell adhesion studies10.1016/j.biomaterials.2007.01.006 ↗
24. Sol–gel derived nitric-oxide releasing materials that reduce bacterial adhesion10.1021/ja0165077 ↗
25. Inhibition of implant-associated infections via nitric oxide release10.1016/j.biomaterials.2005.05.017 ↗
26. Nitric oxide-releasing sol–gels as antibacterial coatings for orthopedic implants10.1016/j.biomaterials.2004.03.031 ↗
27. Antibacterial properties of nitric oxide-releasing sol–gels10.1002/jbm.a.20030 ↗
28. Poly(vinyl chloride)-coated sol–gels for studying the effects of nitric oxide release on bacterial adhesion10.1021/bm049727w ↗
29. In vitro cytotoxicity of nitric oxide-releasing sol–gel derived materials10.1016/j.biomaterials.2004.11.015 ↗
30. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters10.1086/502329 ↗
31. Reducing the risk of catheter-related urinary tract infection
32. Antibacterial effect of silver–zeolite on oral bacteria under anaerobic conditions10.1016/S0109-5641(00)00050-6 ↗
33. Silver supported on natural Mexican zeolite as an antibacterial material10.1016/S1387-1811(00)00217-1 ↗
34. Cytotoxicity of antimicrobial tissue conditioners containing silver–zeolite
35. Antibacterial temporary filling materials: the effect of adding various ratios of Ag–Zn–zeolite10.1046/j.1365-2842.1998.00265.x ↗
36. Pollution by nitrogen oxides: an approach to NO(x) abatement by using sorbing catalytic materials10.1016/j.envint.2004.09.006 ↗
37. Hydrogen storage in low silica type X zeolites10.1021/jp0634508 ↗
38. Hydrogen storage in Chabazite zeolite frameworks10.1039/b509124a ↗
39. Adsorption and desorption behavior of NO on H-ZSM-5, Na-ZSM-5, and Na-A as studied by EPR10.1006/jmre.2002.2504 ↗
40. DeNOx of exhaust gas from lean-burn engines through reversible adsorption of N(2)O(3) in alkali metal cation exchanged faujasite-type zeolites10.1002/1521-3773(20000818)39:16<2934::AID-ANIE2934>3.0.CO;2-E ↗
41. NO-releasing zeolites and their antithrombotic properties10.1021/ja0503579 ↗
42. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation10.1038/sj.jid.5701096 ↗
43. Conjunctival and corneal colonization by Pseudomonas aeruginosa in mechanically ventilated patients. A prospective study10.1016/S0300-2977(99)00037-6 ↗
44. Overview of catheter-related infections with special emphasis on prevention based on educational programs10.1046/j.1469-0691.2002.00467.x ↗
45. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection10.4049/jimmunol.167.3.1778 ↗
46. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens10.1016/S0014-5793(99)00670-5 ↗
47. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia10.1128/mr.60.3.539-574.1996 ↗
48. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit
49. Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro10.1097/00003246-199811000-00028 ↗
50. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections10.1128/JCM.02280-06 ↗
51. Antibacterial properties of nitric oxide-releasing sol–gel microarrays10.1021/bm049632u ↗
52. Reducing implant-related infections: active release strategies10.1039/b515219b ↗
53. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles10.1016/j.biomaterials.2009.01.052 ↗
54. Antibacterial effect of zinc oxide in vitro10.3109/02844319009041278 ↗
55. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 200610.1016/j.ajic.2007.10.009 ↗
56. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes10.1592/phco.27.7.1001 ↗
57. High-capacity hydrogen and nitric oxide adsorption and storage in a metal-organic framework10.1021/ja066098k ↗